|
PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; MSD; Pfizer |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; MSD; Pfizer |
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis; IPSEN,; Janssen; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer/Astellas |
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb/Medarex; Merck; MSD Oncology; Pfizer |
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Pfizer |
|
Matthieu Roulleaux Dugage |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Janssen |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; bristol-myers squibb; Ipsen; LEO Pharma; Lilly; MSD; Pfizer |
|
|
No Relationships to Disclose |
|
|
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis |
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; MSD; Pfizer; Sanofi |
Travel, Accommodations, Expenses - Ipsen |
|
|
Honoraria - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Sanofi |
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Sanofi |
|
|
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck; MSD Oncology; Pfizer |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); MSD (Inst); Roche (Inst); Taiho Oncology (Inst) |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer |
|
|
No Relationships to Disclose |
|
Laetitia Augusto-Pelegrin |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Merck Serono; Pfizer |
Travel, Accommodations, Expenses - Ipsen; Janssen; Janssen; MSD; Pfizer |
|
|
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN |
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer |
Research Funding - IPSEN (Inst) |
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer |